Sec. 101 Reform of the medicare supplemental oxygen benefit
“(A) In general—In carrying out”
“(B) Exclusion of oxygen, and oxygen related equipment, supplies, and services—Beginning on or after January 1, 2025, the Secretary shall exclude oxygen and oxygen related equipment, supplies, and services from the competitive acquisition program under this section and payment for oxygen and oxygen related equipment, supplies, and services shall be made as prescribed under subparagraphs (E), (F), and (H) of section 1834(a)(9).”
“(E) Payment for oxygen and oxygen related equipment, supplies, and services excluded from competitive acquisition program—Subject to subparagraphs (F), (G), and (H) in the case of oxygen and oxygen related equipment, supplies, and services furnished on or after January 1, 2025—
“(i) in areas that are competitive bidding areas in which a competitive bidding program is implemented for other covered items, the payment amount is equal to—
“(I) for 2025, the fee schedule amounts for the area for items and services in effect on December 31, 2024; and
“(II) for each subsequent year, the amount determined under this clause for the preceding year, increased by the percentage increase in the consumer price index for all urban consumers (United States city average) for the 12-month period ending on December 31 of the previous year;
“(ii) in rural areas and non-contiguous areas (Alaska, Hawaii, and U.S. territories), the payment amount is equal to—
“(I) 50 percent of 110 percent of the national average price for the item or service determined under section 414.210 (g)(1)(ii) of title 42, Code of Federal Regulations; and
“(II) 50 percent of—
“(aa) for 2025, the fee schedule amount for the area in effect on December 31, 2024; and
“(bb) for each subsequent year, the amount determined under this subclause for the preceding year, increased by the percentage increase in the consumer price index for all urban consumers (United States city average) for the 12-month period ending on December 31 of the previous year; and
“(iii) in areas other than those described in clauses (i) and (ii), the payment amount is equal to the sum of 75 percent of the adjusted payment amount established under clause (i) and 25 percent of the unadjusted fee schedule amount otherwise determined without taking into account this subparagraph.
“(F) Special rule for liquid oxygen
“(i) Payment
“(I) In general—In lieu of the volume adjustment established under paragraph (5)(C), not later than January 1, 2025, the Secretary in consultation with suppliers, manufacturers, patients and patient advocates, and physicians, and through notice-and-comment rulemaking, shall establish a separate payment amount that meets the requirements of this subparagraph made to a supplier for the provision of liquid oxygen and liquid oxygen related equipment, supplies, and services that meets the requirements described in subparagraph (G).
“(II) Payment floor—The payment amount established under subclause (I) may not be less than an amount equal to 200 percent of the 2015 Durable Medical Equipment, Prosthetics/Orthotics & Supplies Fee Schedule updated by the consumer price index for all urban consumers (United States city average) for years 2016 through 2024.
“(III) Update mechanism—Beginning on January 1, 2026, the payment amount described in subclause (I) shall be increased annually by the projected percentage increase in the consumer price index for all urban consumers (United States city average) for the 12-month period ending December 31 of the previous year.
“(ii) Considerations—In implementing the payment amount under this subparagraph, the Secretary shall take into account the cost of liquid oxygen on a per pound basis, the cost of liquid oxygen equipment, the infrastructure costs associated with providing liquid oxygen equipment and supplies (including labor, storage, transportation, maintenance, and similar costs), the cost of complying with Federal and State regulations specific to the delivery and transportation of liquid oxygen, and any other cost factors the Secretary deems appropriate after consulting with stakeholders such as suppliers, providers, patients and patient advocates, and manufacturers.
“(iii) Monthly add-on for high-flow patients
“(I) In general—Subject to subclause (II), the Secretary shall establish a non-budget neutral add-on to the payment amount under clause (i) when the prescribing practitioner orders an oxygen flow rate equal to or greater than 6 liters per minute.
“(II) Add-on amount—The add-on amount shall equal the per pound cost of the oxygen exceeding the amount required to provide a liter flow that is equal to or greater than 6 liters per minute.
“(iv) Periodic assessment of the base rate—The Secretary shall assess at least once every 3 years the adequacy of the payment amounts under this subparagraph on a cost-related basis or other economical and equitable basis.
“(v) Transitional interim payment
“(I) In general—For items and services furnished on or after the date of the enactment of the SOAR Act of 2024 and prior to the implementation of the payment amount established under this subparagraph, the Secretary shall adopt a transitional interim payment amount for liquid oxygen, and liquid oxygen equipment, supplies, and services in an amount equal to 200 percent of the 2015 Durable Medical Equipment, Prosthetics/Orthotics & Supplies Fee Schedule updated by the consumer price index for all urban consumers (United States city average) for years 2016 through 2024.
“(II) Update—This amount shall be updated annually by the projected percentage change in the consumer price index for all urban consumers (United States city average) for the 12-month period ending on December 31 of the previous year, until the Secretary implements the payment amount under this subparagraph.
“(vi) Coverage criteria
“(I) In general—Not later than January 1, 2025, the Secretary, in consultation with stakeholders, shall establish objective clinical criteria for the coverage of liquid oxygen, and liquid oxygen equipment, supplies, and services under this title.
“(II) Update of criteria—The Secretary shall review and update the coverage standards under this clause every 5 years to ensure the standards take into consideration current medical and clinical guidelines and take into effect modality in order to maximize beneficiary independence.”